ArticleOncotarget2017

Identification of volasertib-resistant mechanism and evaluation of combination effects with volasertib and other agents on acute myeloid leukemia.

Yoshiya Adachi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.